News
A once-daily oral therapy targeting neutrophilic inflammation has shown promise in reducing exacerbations in patients with ...
Discover a study that also highlighted that treatment intensification with enzalutamide benefited patients regardless of ...
A phase 3 clinical trial reports that nerandomilast was associated with a smaller decline in forced vital capacity in ...
A 2024 nationwide survey of French ICUs reveals critical gaps in managing invasive candidiasis, including underutilization of ...
Presented at EuroPCR 2025, the 10-year results of the DANAMI-3-PRIMULTI trial show how complete revascularisation cuts ...
Discover a Phase 3 trial that evaluated stapokibart as an additional therapy for adults with moderate-to-severe seasonal ...
I'm a clinical academic, which is quite a rare breed of doctor, because what I'm doing, along with other clinical academics, ...
In people living with HIV, gut microbiome differences linked to antiretroviral therapy and weight gain are small compared to ...
Presented at EuroPCR 2025, the results of this meta-analysis show why routine cerebral embolic protection may not prevent ...
Discover a study about an AI model named PLAN-B-DF that has been developed to improve the prediction of hepatocellular ...
New research, from COMy 2025, has found that specific senescence-associated biomarkers are significantly correlated with ...
A new review examines the effectiveness of surgical treatments for severe osteoarthritis, highlighting the dominance of total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results